| Role of the oncogenic Raf-1 in orchestration of discrete nuclear factor-kappaB-activating pathways. | None |
| Raf-1 protein kinase is an integral component of the oncogenic signal cascade shared by epidermal growth factor and platelet-derived growth factor. | None |
| Induction of C-X-C chemokines, growth-related oncogene alpha expression, and epithelial cell-derived neutrophil-activating protein-78 by ML-1 (interleukin-17F) involves activation of Raf1-mitogen-activated protein kinase kinase-extracellular signal-regulated kinase 1/2 pathway. | None |
| Deregulated expression of interferon regulatory factor-1 in oncogene-transformed mouse fibroblasts. | None |
| Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1. | None |
| Localization of the 5 end of the MCF2 oncogene to human chromosome 15q15----q23. | None |
| Back to the roots: the remarkable RAF oncogene story. | None |
| Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf. | None |
| Clonally related IL-7-independent tumors induced by oncogenes abl + myc or raf + myc have reduced sensitivity to TGF-beta1. | None |
| Xenopus c-raf proto-oncogene: cloning and expression during oogenesis and early development. | None |
| These results suggest that oncogenic ras-p21 induces phosphorylation of both raf-Ser259 and Ser338 and that raf-Ser 259 phosphorylation may be effected by activated JNK. | None |
| Proto-Oncogene Proteins c-akt negatively regulates Proto-Oncogene Proteins c-raf activation (Ser259), partially explaining the difference between resistant and intermediate cells. | None |
| Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. | None |
| Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. | None |
| Protein kinase C epsilon regulates translocator protein Tspo gene expression through a proto-oncogene protein Raf-1-MAP-kinase signal transduction pathway, acting at least in part through c-Jun and STAT3 transcription factors. | None |
| Cerebral ischemia induces transient intracellular redistribution and intranuclear translocation of the raf proto-oncogene product in hippocampal pyramidal cells. | None |
| [The c-raf oncogene]. | None |
| Azatyrosine inhibits the activation of c-Raf-1, c-Jun and AP1 but not the activation of Ras during signal transduction triggered by oncogenic c-ErbB-2. | None |
| Insulin activates the kinase activity of the Raf-1 proto-oncogene by increasing its serine phosphorylation. | None |
| Conditional expression of oncogenic C-RAF in mouse pulmonary epithelial cells reveals differential tumorigenesis and induction of autophagy leading to tumor regression. | None |